1042 related articles for article (PubMed ID: 16381186)
41. Current clinical results of the Tsukuba BNCT trial.
Yamamoto T; Matsumura A; Nakai K; Shibata Y; Endo K; Sakurai F; Kishi T; Kumada H; Yamamoto K; Torii Y
Appl Radiat Isot; 2004 Nov; 61(5):1089-93. PubMed ID: 15308197
[TBL] [Abstract][Full Text] [Related]
42. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data.
Zamenhof R; Redmond E; Solares G; Katz D; Riley K; Kiger S; Harling O
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):383-97. PubMed ID: 8635948
[TBL] [Abstract][Full Text] [Related]
43. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958
[TBL] [Abstract][Full Text] [Related]
44. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447
[TBL] [Abstract][Full Text] [Related]
45. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
46. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
[TBL] [Abstract][Full Text] [Related]
47. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
48. Clinical results of BNCT for malignant brain tumors in children.
Nakagawa Y; Kageji T; Mizobuchi Y; Kumada H; Nakagawa Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S27-30. PubMed ID: 19406652
[TBL] [Abstract][Full Text] [Related]
49. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
[TBL] [Abstract][Full Text] [Related]
50. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
[TBL] [Abstract][Full Text] [Related]
51. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
52. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH
J Neurooncol; 1997 May; 33(1-2):59-70. PubMed ID: 9151224
[TBL] [Abstract][Full Text] [Related]
53. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
[TBL] [Abstract][Full Text] [Related]
54. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
55. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
Morris GM; Micca PL; Coderre JA
Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
[TBL] [Abstract][Full Text] [Related]
56. Boronated dipeptide borotrimethylglycylphenylalanine as a potential boron carrier in boron neutron capture therapy for malignant brain tumors.
Takagaki M; Powell W; Sood A; Spielvogel BF; Hosmane NS; Kirihata M; Ono K; Masunaga SI; Kinashi Y; Miyatake SI; Hashimoto N
Radiat Res; 2001 Jul; 156(1):118-22. PubMed ID: 11418080
[TBL] [Abstract][Full Text] [Related]
57. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
[TBL] [Abstract][Full Text] [Related]
58. Boron neutron capture therapy for malignant gliomas.
Diaz AZ; Coderre JA; Chanana AD; Ma R
Ann Med; 2000 Feb; 32(1):81-5. PubMed ID: 10711581
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
[TBL] [Abstract][Full Text] [Related]
60. Boron neutron capture therapy at the crossroads: challenges and opportunities.
Barth RF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]